@article{506f3247f82e4c3e9a381a3d9b532ce4,
title = "Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline",
abstract = "This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized controlled trials evaluating interventions to prevent (1) acute phase CINV and (2) delayed phase CINV. Recommendations for acute phase and delayed phase CINV prophylaxis are made for patients receiving chemotherapy of varying emetogenicity, as well as for patients not able to receive dexamethasone or a neurokinin-1 receptor antagonist. Evidence gaps, including antiemetic safety and optimal dosing, were identified.",
keywords = "chemotherapy-induced nausea and vomiting, guideline, pediatric oncology, supportive care, Nausea/chemically induced, Humans, Neoplasms/drug therapy, Randomized Controlled Trials as Topic, Vomiting/chemically induced, Systematic Reviews as Topic, Antineoplastic Agents/adverse effects, Child, Antiemetics/therapeutic use",
author = "Priya Patel and Robinson, {Paula D.} and Marie Cohen and Katie Devine and Paul Gibson and Holdsworth, {Mark T.} and Eloise Neumann and Andrea Orsey and Robert Phillips and Daniela Spinelli and Jennifer Thackray and {van de Wetering}, Marianne and Deborah Woods and Sandra Cabral and Lillian Sung and Dupuis, {L. Lee}",
note = "{\textcopyright} 2022 Wiley Periodicals LLC.",
year = "2022",
month = dec,
doi = "10.1002/pbc.30001",
language = "English",
volume = "69",
pages = "e30001",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "12",
}